Evidence map›Paper›PMID 41651425›Full record

ReviewThe Journal of biological chemistry2026

Unusual and atypical cyclooxygenase reactions.

Claus Schneider, Alan R Brash

Abstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Claus SchneiderDepartment of Pharmacology and the Vanderbilt Institute of Chemical Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. Electronic address: claus.schneider@vanderbilt.edu.
Alan R BrashDepartment of Pharmacology and the Vanderbilt Institute of Chemical Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. Electronic address: alan.brash@vanderbilt.edu.

Funding

Novel pathways in eicosanoid biosynthesis and metabolismR35GM144091 · NIGMS · VANDERBILT UNIVERSITY · PI Claus Schneider · 2022 to 2026
$2.4M
Analytical approaches to fatty acid oxygenases and their lipid mediator productsR35GM152031 · NIGMS · VANDERBILT UNIVERSITY · PI ALAN R. BRASH · 2024 to 2026
$1.2M
NIGMS NIH HHS R35 GM144091NIGMS NIH HHS R35 GM152031
6 · The paper itself

Abstract

Mechanistic studies have yielded novel prostaglandin analogs and acyclic products initially of interest in understanding cyclooxygenase (COX) structure and function, later found in vivo and of interest because of unique biological activities. Beyond arachidonic acid, fatty acid substrates span from 18 to 22 carbons and may contain ester/amide modification or epoxide/hydroxy moieties at the first double bond. Stereocontrol with the unconventional substrates remains largely intact although cyclization may be diverted or halted altogether, and catalysis proceeds with the insertion of one, two, or three molecules of oxygen into substrates. A switch in stereochemistry at the 15-carbon occurs in a natural COX from coral and has received attention upon aspirin treatment of COX-2. The latter produces 15R-hydroxyeicosatetraenoic acid and analogs from other fatty acids that may be further oxygenated by lipoxygenases. Functional plasticity in COX catalysis has enabled the formation and discovery of a host of novel eicosanoids and provided mechanistic insight into the COX reaction mechanisms.

Indexed as

Prostaglandin-Endoperoxide SynthasesAnimalsCyclooxygenase InhibitorsHumansProstaglandinsCyclooxygenase InhibitorsProstaglandin-Endoperoxide SynthasesProstaglandinsarachidonic acidaspirincyclooxygenasedrug actioneicosanoidenzyme catalysisenzyme functional plasticityfish oiloxylipinprostaglandinstereocontrol

Identifiers

PMID41651425
PMCPMC12966737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.